THE HINDU BUSINESS LINE
Financial Daily
from THE HINDU group of publications

Friday, October 12, 2001

• AGRI-BUSINESS
• CORPORATE
• INDUSTRY
• MACRO ECONOMY
• MARKETS
• NEWS
• OPINION
• INFO-TECH
• CATALYST
• INVESTMENT WORLD
• MONEY & BANKING
• LOGISTICS

• PAGE ONE
• INDEX
• HOME

Markets | Next | Prev


GlaxoSmithKline - VRS is no big deal

GLAXOSMITHKLINE'S decision to go ahead with a VRS programme for about 622 employees in unlikely to have an immediate impact on its share price. The VRS is in keeping with the company's desire to eliminate superfluous cost, but a change in its valuation c an come about only when its sales show signs of picking up. - BL Research Bureau

Related links:
Glaxo SmithKline offers VRS for Worli unit workers

Comment on this article to BLFeedback@thehindu.co.in

Send this article to Friends by E-Mail


Next: Hind Oil - No open offer implication
Prev: HDFC: Strong, sound investments
Markets

Agri-Business | Corporate | Industry | Macro Economy | Markets | News | Opinion | Info-Tech | Catalyst | Investment World | Money & Banking | Logistics |

Page One | Index | Home


Copyright © 2001 The Hindu Business Line.

Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line.